Lennon David James
- SEC CIK
- 0001995275
In the past year, 4 open-market sale filings worth $1.06M and no purchases.
Current role at each company
- WHWK Whitehawk Therapeutics, Inc.CHIEF EXECUTIVE OFFICERas of Sep 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.06M
- 4 filings
- Net
- −$1.06M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lennon David James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2026 (view filing) | Apr 9 | 1 day | Lennon David JamesCHIEF EXECUTIVE OFFICER | SSale | −14.5K | $3.38 | −$49.0K | −2.7%518.6K after | |
| Apr 8, 2026 (view filing) | Apr 6-8 | 2 days | Lennon David JamesCHIEF EXECUTIVE OFFICER | SSale | −260.4K | $3.45 | −$899.5K | −32.8%533.1K after | 3 lots |
| Apr 3, 2026 (view filing) | Apr 2 | 1 day | Lennon David JamesCHIEF EXECUTIVE OFFICER | SSale | −26.9K | $3.48 | −$93.5K | −3.3%793.5K after | |
| Mar 10, 2026 (view filing) | Mar 2 | 8 daysLate | Lennon David JamesCHIEF EXECUTIVE OFFICER | SSale | −5.10K | $3.31 | −$16.9K | −10.3%44.6K after | |
| Mar 3, 2025 (view filing) | Mar 3 | Same day | Lennon David JamesCHIEF EXECUTIVE OFFICER | SSale | −5.69K | $2.35 | −$13.4K | −14.5%33.4K after | |
| Oct 3, 2024 (view filing) | Oct 3 | Same day | Lennon David JamesCHIEF EXECUTIVE OFFICER | SSale | −9.69K | $1.94 | −$18.8K | −29.8%22.9K after |